Fresenius SE & Co KGaA
(XTER:FRE)
€
29.56
-0.37 (-1.24%)
Market Cap: 16.65 Bil
Enterprise Value: 30.13 Bil
PE Ratio: 0
PB Ratio: 0.87
GF Score: 71/100 - Q1 2024 Fresenius SE & Co KGaA Earnings Call TranscriptMay 08, 2024€28.48 (+1.24%)Earnings
- Full Year 2023 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 21, 2024€26.2 (+0.61%)Earnings
- Q3 2023 Fresenius SE & Co KGaA Earnings Call TranscriptNov 02, 2023€25.72 (+5.84%)Earnings
- Q2 2023 Fresenius SE & Co KGaA Earnings Call TranscriptAug 02, 2023€28.57 (-0.38%)Earnings
- Fresenius SE & Co KGaA Capital Markets Day 2023 TranscriptMay 25, 2023
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 17, 2023
- Q1 2023 Fresenius SE & Co KGaA Earnings Call TranscriptMay 09, 2023€27.66 (+8.73%)Earnings
- Q4 2022 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 22, 2023€27.59 (-4.37%)Earnings
- Q3 2022 Fresenius SE & Co KGaA Earnings Call TranscriptNov 01, 2022€23.26 (+4.96%)Earnings
- Preliminary Q2 2022 Fresenius SE & Co KGaA Earnings Call TranscriptJul 28, 2022€25.02 (-8.15%)Earnings
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 13, 2022
- Q1 2022 Fresenius SE & Co KGaA Earnings Call TranscriptMay 04, 2022€35.07 (+3.14%)Earnings
- Fresenius SE & Co KGaA and Fresenius Kabi AG Conference Call on the Acquisition of Ivenix Inc and Majority Stake in mAbxience SA Call TranscriptMar 31, 2022
- Full Year 2021 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 22, 2022€33.45 (-8.39%)Earnings
- Fresenius SE & Co KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Fresenius SE & Co KGaA Earnings Call TranscriptNov 02, 2021€40.72 (+2.20%)Earnings
- Q2 2021 Fresenius SE & Co KGaA Earnings Call TranscriptJul 30, 2021€44.24 (-3.93%)Earnings
- Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 21, 2021
- Q1 2021 Fresenius SE & Co KGaA Earnings Call TranscriptMay 06, 2021€41.51 (+0.47%)Earnings
- Full Year 2020 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 23, 2021€35.56 (-0.70%)Earnings
- Fresenius SE & Co KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Fresenius SE & Co KGaA Earnings Call TranscriptOct 29, 2020€31.49 (-2.53%)Earnings
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptAug 28, 2020
- Q2 2020 Fresenius SE & Co KGaA Earnings Call TranscriptJul 30, 2020€42.52 (-5.59%)Earnings
- Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Q1 2020 Fresenius SE & Co KGaA Earnings Call TranscriptMay 06, 2020€39.7 (+1.02%)Earnings
- Full Year 2019 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 20, 2020€49.65 (+2.26%)Earnings
- Fresenius SE & Co KGaA at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Fresenius SE & Co KGaA at Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 13, 2019
- Q3 2019 Fresenius SE & Co KGaA Earnings Call TranscriptOct 29, 2019€45.69 (+4.57%)Earnings
- Q2 2019 Fresenius SE & Co KGaA Earnings Call TranscriptJul 30, 2019€44.85 (-2.13%)Earnings
- Fresenius SE & Co KGaA Annual Shareholders Meeting TranscriptMay 17, 2019
- Q1 2019 Fresenius SE & Co KGaA Earnings Call TranscriptMay 02, 2019€50.66 (+0.34%)Earnings
- Full Year 2018 Fresenius SE & Co KGaA Earnings Call TranscriptFeb 20, 2019€48.91 (+4.97%)Earnings
Fresenius SE & Co KGaA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021 / 12:00PM GMT
Release Date Price:
€45.15
(+0.96%)
Veronika Dubajova
Goldman Sachs Group, Inc., Research Division - Equity Analyst
Good afternoon. Good morning, and good evening, ladies and gentlemen, and thank you for joining us second day of the Goldman Sachs 42nd Annual Global Healthcare Conference. It is with great pleasure that I am kicking us off today with Fresenius SE represented by Stephan Sturm, Chairman of the Management Board; and Markus Georgi, Head of IR. Thank you guys for being here.
Stephan Sturm
Fresenius SE & Co. KGaA - CEO, President & Chairman of Management Board - Fresenius Management SE
Hope everybody is well.
Veronika Dubajova
Goldman Sachs Group, Inc., Research Division - Equity Analyst
Excellent. I'm going to kick us off with some questions, but just from a logistical perspective, if anyone would like me to ask a question, please, you can either submit them on the webcast chat or you can e-mail me directly at [email protected], and I promise I will ask that question. But let me kick off with my own, if that's all right,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)